MULTIPLE-SCLEROSIS - EFFECT OF CLINICAL-DISEASE ACTIVITY AND INTERFERON BETA-1B TREATMENT ON BLOOD AND CEREBROSPINAL-FLUID IMMUNOLOGICAL PARAMETERS AND URINARY MYELIN BASIC PROTEIN-LIKE MATERIAL
Rw. Baumhefner et al., MULTIPLE-SCLEROSIS - EFFECT OF CLINICAL-DISEASE ACTIVITY AND INTERFERON BETA-1B TREATMENT ON BLOOD AND CEREBROSPINAL-FLUID IMMUNOLOGICAL PARAMETERS AND URINARY MYELIN BASIC PROTEIN-LIKE MATERIAL, Annals of neurology, 38(2), 1995, pp. 315-315